|Day Low/High||23.41 / 24.44|
|52 Wk Low/High||25.51 / 31.08|
Animal health and oncology deal activity is heating up in 2017.
The Mars-VCA deal is yet another sign that pet health is a robust business.
Stocks trade mostly lower with the Dow Jones Industrial Average taking a pause in its race toward 20,000.
Jim Cramer says the deal between Mars and VCA is another example of how pet pampering is becoming big business.
With poor breadth and money managers hiding in large-caps, I am being cautious, right now.
M&Ms maker Mars is acquiring pet health care services provider VCA in a $9.1 billion deal, including $1.4 billion in outstanding debt.
The humanization of pets has sent spending soaring, which has some pet-related stock seeing major benefits.
Shares of VCA are down 6.6% year-to-date, but don’t put the pet healthcare purveyor in the doghouse just yet.
Douglas Kelly, analyst at IBISWorld, discusses a few unlikely sectors where he is finding growth alternatives.
TheStreet hits the street at The Salty Paw in NYC to discuss whether people are starting to spend less on their pets. Could PetSmart pause